Skip to content

Increasing Availability and Acceptability of Circumcision in Zambia

Increasing Availability and Acceptability of Circumcision in Zambia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01688167
Enrollment
1468
Registered
2012-09-19
Start date
2012-01-31
Completion date
2014-11-30
Last updated
2022-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Keywords

HIV, Male circumcision, Sexual risk reduction, Stages of change

Brief summary

This study proposes to balance supply and demand of male circumcision through a systematic scale-up of coordinated biomedical surgical and behavioral counseling services. The study will compare the combined biobehavioral sexual risk reduction intervention to the standard of care, which focuses exclusively on the provision of circumcision services alone, with the goal of optimizing both local and national HIV prevention efforts.

Interventions

BEHAVIORALMC and sexual risk reduction

Four group counselling sessions focused on male circumcision and sexual risk reduction

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* HIV negative * Uncircumcised male * 18+ years of age * Able to understand and sign informed consent in English, Bemba, or Nyanja * Have not requested male circumcision services at the time of or following VCT * Female partners of enrolled males are invited to participate

Exclusion criteria

* Men seeking circumcision services are not eligible for this study * Men with genital abnormalities requiring MC, e.g. balanitis (inflammation of the preputial skin), posthitis (inflammation of the glans penis; common in patients with diabetes), phimosis (scarring of the distal margins of the foreskin) resulting from chronic balanitis, paraphimosis (the inability to pull the retracted foreskin back over the glans) or diseases of the foreskin, including localized carcinoma are not eligible for this study * Men with congenital or acquired penile abnormalities that require the preputial skin for generative repair, such as hypospadias (urethra exits from underside of penis) are not eligible to participate * Participants unable to provide informed consent will not be eligible.

Design outcomes

Primary

MeasureTime frameDescription
Change in likelihood of undergoing male circumcision across the study using stages of change modelBaseline, Average of 1 month post-baseline, 6 month and 12 month follow-upReadiness to undergo male circumcision will be assessed using the stages of change model (pre-contemplation, contemplation, preparation, action, maintenance). Intervention and attention control conditions will be compared at baseline, immediately following intervention, and 6 and 12 months post-intervention.

Secondary

MeasureTime frameDescription
Uptake of male circumcisionFrom the date of study enrollment to the date male circumcision is performed or study completion.To determine if participants in the sexual risk reduction/MC promotion intervention (experimental condition) will be more likely to shift to the Action stage (undergo circumcision), in comparison with participants having identical MC services available plus usual care (attention control condition).

Other

MeasureTime frameDescription
Male and female condom use post male circumcision3 months after undergoing male circumcisionTo determine whether MC will significantly affect the maintenance of safer sexual practices (risk compensation) in the experimental group as compared to the attention control group

Countries

Zambia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 17, 2026